BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 12777736)

  • 1. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer.
    Duffy JP; Eibl G; Reber HA; Hines OJ
    Mol Cancer; 2003 Jan; 2():12. PubMed ID: 12605718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of photodynamic therapy on tumor angiogenesis.
    Bhuvaneswari R; Gan YY; Soo KC; Olivo M
    Cell Mol Life Sci; 2009 Jul; 66(14):2275-83. PubMed ID: 19333552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The eIF4E RNA regulon promotes the Akt signaling pathway.
    Culjkovic B; Tan K; Orolicki S; Amri A; Meloche S; Borden KL
    J Cell Biol; 2008 Apr; 181(1):51-63. PubMed ID: 18391071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
    J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation.
    Cao Y; Li CY; Moeller BJ; Yu D; Zhao Y; Dreher MR; Shan S; Dewhirst MW
    Cancer Res; 2005 Jul; 65(13):5498-505. PubMed ID: 15994919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Pastorek J; Karapantzos I; Gatter KC; Harris AL;
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):67-71. PubMed ID: 15093900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppression through angiogenesis inhibition.
    Arsham AM; Simon MC
    Methods Mol Biol; 2003; 223():249-70. PubMed ID: 12777736
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.
    Acker T; Plate KH
    Cell Tissue Res; 2003 Oct; 314(1):145-55. PubMed ID: 12898211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in chronic liver disease and its complications.
    Coulon S; Heindryckx F; Geerts A; Van Steenkiste C; Colle I; Van Vlierberghe H
    Liver Int; 2011 Feb; 31(2):146-62. PubMed ID: 21073649
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.